The Feasibility of Using Cannabis in Veterinary Medicine
List all Project Mentors & Advisor(s)
Dr. William DeWees
Presentation Format
Poster Presentation
Abstract/Description
With discussions surrounding the legalization of cannabis for medicinal and recreational purposes gaining popularity within the United States, this presentation will look at the benefits and risks of using plants within the Cannabis genus in veterinary medicine. The viability of cannabis use as compared to drugs currently used to treat symptoms such as poor appetite and seizures will occur in order to determine if it is feasible for Cannabis sativa to gain a place in conventional veterinary practices. A focus on hemp, a variety of Cannabis sativa that produces less than 0.3% THC, will occur in light of the recent research permits granted within the state of Kentucky. Comparisons between cannabis administration to patients and the administration of current drugs of choice will be made on the basis of efficacy, cost, and known risks.
Location
Small Ballroom, Curris Center
Start Date
April 2016
End Date
April 2016
Affiliations
Honors Thesis
The Feasibility of Using Cannabis in Veterinary Medicine
Small Ballroom, Curris Center
With discussions surrounding the legalization of cannabis for medicinal and recreational purposes gaining popularity within the United States, this presentation will look at the benefits and risks of using plants within the Cannabis genus in veterinary medicine. The viability of cannabis use as compared to drugs currently used to treat symptoms such as poor appetite and seizures will occur in order to determine if it is feasible for Cannabis sativa to gain a place in conventional veterinary practices. A focus on hemp, a variety of Cannabis sativa that produces less than 0.3% THC, will occur in light of the recent research permits granted within the state of Kentucky. Comparisons between cannabis administration to patients and the administration of current drugs of choice will be made on the basis of efficacy, cost, and known risks.